Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Moderna, inc. symbols : SNYNF save search
Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Published: 2024-03-27 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: 2.02%
H: 1.41%
C: 0.92%
vaccine trials
Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
Published: 2024-02-01 (Crawled : 23:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -4.37%
H: 0.0%
C: 0.0%
MRK | $125.03 -0.27% 2.6M
|
Health Technology
|
| O: 2.38%
H: 2.25%
C: 2.21%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: -0.15%
H: 0.1%
C: -1.86%
HARP | $23.01 0.07% 6.6M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
merck financial results
Global mRNA-based Vaccines and Therapeutics Market is Projected to Grow Immensely During the Study Period (2019-2032) | DelveInsight
Published: 2024-01-25 (Crawled : 23:00) - prnewswire.com
MTLHY | $29.93 1.1K
|
n/a
|
| O: -1.11%
H: 0.1%
C: 0.1%
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: -1.82%
VRTX | $393.46 0.09% 350K
|
Health Technology
|
| O: 0.25%
H: 0.27%
C: -0.2%
SLN | $21.945 1.79% 45K
|
Health Technology
|
| O: 4.32%
H: 0.0%
C: -3.68%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: 0.72%
H: 0.34%
C: -1.68%
MRUS | $40.5 -1.34% 99K
|
Health Technology
|
| O: 0.35%
H: 2.81%
C: -0.53%
ICLR | $292.77 0.26% 310K
|
Health Technology
|
| O: 1.13%
H: 0.82%
C: -0.74%
BNTX | $86.015 -0.45% 280K
|
Health Technology
|
| O: -1.35%
H: 0.12%
C: -0.83%
global therapeutics study market
Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates
Published: 2023-11-02 (Crawled : 12:00) - biospace.com/
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 3.0%
H: 0.0%
C: 0.0%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: -15.55%
H: 13.91%
C: 10.69%
business financial results
Merck Announces Third-Quarter 2023 Financial Results
Published: 2023-10-26 (Crawled : 11:00) - biospace.com/
MRK | $125.03 -0.27% 2.6M
|
Health Technology
|
| O: -0.51%
H: 4.0%
C: 2.38%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: -0.04%
H: 0.64%
C: -0.98%
merck financial results
Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company's Combination Vaccine Against Influenza and COVID-19
Published: 2023-10-04 (Crawled : 12:00) - biospace.com/
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: 1.48%
H: 0.2%
C: -0.33%
rna-1083 covid-19 vaccine positive influenza
RNA Therapeutics Market worth $18.0 billion | MarketsandMarkets
Published: 2023-09-15 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
ALPMY | News | $9.46 500K
|
Manufacturing
|
| O: 3.0%
H: 0.0%
C: -3.43%
PFE A | $25.325 -0.37% 25M
|
Health Technology
|
| O: -0.26%
H: 1.04%
C: 0.03%
NVS | News | $92.53 -0.59% 670K
|
Health Technology
|
| O: 1.51%
H: 0.26%
C: -0.72%
SRPT | $117.05 -0.71% 150K
|
Health Technology
|
| O: -0.27%
H: 0.54%
C: -0.84%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: 0.16%
H: 2.0%
C: 1.42%
IONS | $41.14 0.56% 210K
|
Health Technology
|
| O: -0.57%
H: 0.35%
C: -1.11%
BNTX | $86.015 -0.45% 280K
|
Health Technology
|
| O: 0.17%
H: 0.48%
C: -0.82%
ARWR | $22.57 0.18% 630K
|
Health Technology
|
| O: 0.16%
H: 0.46%
C: -5.46%
ALNY | $144.675 -0.44% 130K
|
Health Technology
|
| O: -0.74%
H: 2.42%
C: -3.47%
therapeutics market
Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner
Published: 2023-08-29 (Crawled : 12:00) - prnewswire.com
OMGA | $2.44 -4.5% 290K
|
|
| O: 1.66%
H: 9.24%
C: 6.52%
SANA | $7.755 -6.11% 1.2M
|
|
| O: 0.0%
H: 1.07%
C: -2.35%
MCRB | $0.5992 -4.48% 2.4M
|
Health Technology
|
| O: -0.56%
H: 1.84%
C: 0.56%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: -0.07%
H: 2.36%
C: 1.97%
FHTX | $5.71 -1.21% 55K
|
Health Technology
|
| O: 0.0%
H: 3.05%
C: 2.79%
DNLI | $16.69 -0.77% 430K
|
Health Technology
|
| O: 0.09%
H: 1.18%
C: 0.66%
growth
Global mRNA Vaccine and Therapeutics Market Research Report 2023: Market to Decrease by a CAGR of 34.01% to 2028
Published: 2023-05-17 (Crawled : 02:00) - prnewswire.com
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: -0.69%
H: 2.21%
C: 1.06%
BNTX | $86.015 -0.45% 280K
|
Health Technology
|
| O: 2.31%
H: 0.35%
C: -2.67%
report vaccine mrna research global therapeutics market
Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results
Published: 2023-02-02 (Crawled : 14:00) - biospace.com/
ALPMY | News | $9.46 500K
|
Manufacturing
|
| O: 1.22%
H: 0.0%
C: -1.61%
MRK | $125.03 -0.27% 2.6M
|
Health Technology
|
| O: -2.77%
H: 1.72%
C: -0.54%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -0.37%
H: 1.07%
C: 0.66%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -1.44%
H: 0.0%
C: 0.0%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: -0.52%
H: 1.92%
C: 1.7%
financial results
Worldwide Vaccines Industry to 2029 - Combination Vaccines Remain a Significant Growth Contributor to Vaccine Spaces
Published: 2023-01-06 (Crawled : 21:00) - prnewswire.com
JNJ | News | $144.54 -0.16% 4.9M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 510
|
Health Technology
| Email alert
Add to watchlist
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.2 -1.01% 1.2M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 1.4K
|
Health Technology
| Email alert
Add to watchlist
vaccine growth
DelveInsight Evaluates a Robust RNA Interference Pipeline as Key 85+ Pharma Companies Set Foot in the RNA Interference Space
Published: 2022-11-01 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 7.74%
H: 0.17%
C: 0.17%
JNJ | News | $144.54 -0.16% 4.9M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
LLY | News | $745.46 -0.71% 940K
|
Health Technology
|
| O: -4.49%
H: 3.81%
C: 1.95%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: 2.95%
H: 2.66%
C: -0.1%
CVAC | $2.485 -3.31% 370K
|
Health Technology
|
| O: 1.1%
H: 3.4%
C: -1.36%
BNTX | $86.015 -0.45% 280K
|
Health Technology
|
| O: 4.54%
H: 4.25%
C: 0.13%
ALNY | $144.675 -0.44% 130K
|
Health Technology
|
| O: 1.06%
H: 2.53%
C: 1.75%
space pharma companies set
$12+ Billion Influenza Vaccines Market to Grow at 7+% CAGR, Globally, by 2028 Lead by Quadrivalent Vaccines Segment with 88.36% Market Share in 2022 | The Insight Partners
Published: 2022-10-28 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 3.33%
H: 0.74%
C: -1.67%
GSK | $39.2 -1.01% 1.2M
|
Health Technology
|
| O: 0.89%
H: 1.3%
C: 0.79%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 2.57%
H: 0.0%
C: 0.0%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: -0.88%
H: 5.85%
C: 5.69%
influenza market vaccine
Merck Announces Third-Quarter 2022 Financial Results
Published: 2022-10-27 (Crawled : 11:00) - biospace.com/
MRK | $125.03 -0.27% 2.6M
|
Health Technology
|
| O: 1.45%
H: 1.66%
C: -0.1%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: 0.97%
H: 2.0%
C: 0.51%
financial results
Global $12.27 Bn Influenza Vaccines Markets, 2022-2028: Strong Pipeline Candidates & Opportunities in Emerging Economies
Published: 2022-09-09 (Crawled : 12:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -1.6%
H: 6.13%
C: 6.13%
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 4.47%
H: 0.0%
C: 0.0%
GSK | $39.2 -1.01% 1.2M
|
Health Technology
|
| O: 1.4%
H: 0.06%
C: -0.19%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 2.11%
H: 0.0%
C: 0.0%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: 0.54%
H: 0.43%
C: 0.17%
global influenza vaccine
Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight
Published: 2022-08-31 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 0.75%
H: 1.98%
C: 1.98%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
NVAX | $3.92 0.77% 1.3M
|
Health Technology
|
| O: 1.39%
H: 1.34%
C: -7.48%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: 0.75%
H: 2.14%
C: -3.42%
CDTX | $0.729 0.94% 170K
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: -3.37%
companies influenza
Revolution Medicines Appoints Lorence Kim, M.D., Accomplished Health Care Industry Leader, to Board of Directors
Published: 2022-07-13 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: -2.06%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -1.38%
H: 0.0%
C: 0.0%
RVMD S | $36.21 -1.66% 420K
|
Health Technology
|
| O: -2.8%
H: 7.41%
C: 5.9%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: -3.41%
H: 4.6%
C: 1.4%
care health
New Variants Throw the Spotlight on Booster Shots of COVID-19 Vaccines - According to New Research from StrategyR
Published: 2022-03-10 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 2.52%
H: 1.67%
C: 1.67%
JNJ | News | $144.54 -0.16% 4.9M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
NVAX | $3.92 0.77% 1.3M
|
Health Technology
|
| O: -1.99%
H: 2.84%
C: 0.35%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: -2.09%
H: 0.95%
C: 0.01%
covid-19 research covid vaccine
Global COVID-19 Vaccines Market Report 2022: Leading Vaccine Companies Stress on Booster Dose
Published: 2022-02-02 (Crawled : 21:00) - prnewswire.com
JNJ | News | $144.54 -0.16% 4.9M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
NVAX | $3.92 0.77% 1.3M
|
Health Technology
|
| O: -4.8%
H: 4.69%
C: -0.33%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: -3.66%
H: 3.05%
C: -0.68%
covid-19 covid report vaccine
As Omicron Strain Fuels Fresh Waves of Infections Across the Globe, Mutating Coronavirus is the New Pandemic Challenge in 2022
Published: 2022-01-04 (Crawled : 17:00) - prnewswire.com
JNJ | News | $144.54 -0.16% 4.9M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -2.03%
H: 0.0%
C: 0.0%
NVAX | $3.92 0.77% 1.3M
|
Health Technology
|
| O: -2.03%
H: 1.27%
C: -1.11%
MRNA | News S | $102.53 -0.88% 1.1M
|
Health Technology
|
| O: -1.15%
H: 0.0%
C: 0.0%
infection infections
Gainers vs Losers
| 69% | 31% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
ISPC | $0.4621 116.95% 15M
|
Professional, Scientific, and T...
INVO | $1.515 99.34% 4.3M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
XPON | $2.63 36.27% 8.4M
|
PRTG | $0.299 35.17% 120K
|
Mining, Quarrying, and Oil and ...
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
SWVL | $9.64 27.35% 200K
|
n/a
DFLI A | $0.7726 25.52% 4.3M
|
Your saved searches
Save your searches and get alerts when important news are released.